MedShift has announced the completion of its first round of equity funding raising $8 million at a post money valuation of $150 million.
MedShift is a subscription service provider that helps medical practices bring in the latest equipment and technology with no upfront or capital costs to remain competitive and attract new patients.
“We look forward to utilizing this opportunity to further establish MedShift as a leading medical technology innovator. The world is embracing medical aesthetics more than ever, so the new investment will be a valuable asset as MedShift continues to move the needle in the industry. MedShift’s technology and business model is unlike anything seen before, and it's exciting to be at the forefront,” says CEO Brian Phillips.
MedShift finished as the 15th fastest-growing health company in the U.S. in 2020, according to the Inc. 5,000 list.
